Day D, McCarthy M, Talaber I, et al. - For the treatment of androgenetic alopecia (AGA), the treatment was effective, confirmed by a decrease in AGA grade and by blinded evaluation of global photographs. The outcomes imply that the non-ablative Er:YAG laser SMOOTH^™ mode as a monotherapy, or in combination with PRP, is an efficient and safe treatment for AGA—with a high satisfaction rate among patients regardless of patient age, AGA duration, or AGA stage, although the possible additive or complementary effect of topical minoxidil or nutraceuticals cannot be excluded.

• Compared with baseline, AGA grade after treatment was lower (p = 0.015 and p = 0.125 in female and male patients, respectively).

• The Blind assessment demonstrated an improvement in hair quality in 93% of patients, either being described as much better (14%) or as better (79%), which was not correlated with age or AGA grade.

• As per the findings, 3 was the median satisfaction score, and the median VAS score for pain was 2.

• Notably, the positive effect of the treatment on hair quality is ongoing.

• There were no adverse reactions.